![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MIV, SagaX Sign Letter of Intent for Embolic-Protection Technology
MIV, SagaX Sign Letter of Intent for Embolic-Protection Technology
MIV Therapeutics and SagaX Medical Technologies announced that they have entered into a letter of intent regarding SagaX's next generation embolic-protection technology for stroke patients. The parties hope to negotiate and execute definitive agreements regarding the transaction within the next few weeks.
PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=215230)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct